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β-Glucan derived from cell walls of Candida albicans is a potent immune modulator.
It has been shown to induce trained immunity in monocytes via epigenetic and
metabolic reprogramming and to protect from lethal sepsis if applied prior to infection.
Since β-glucan-trained monocytes have not been classified within the system of
mononuclear phagocytes we analyzed these cells metabolically, phenotypically and
functionally with a focus on monocyte-to-macrophage differentiation and compared
them with naïve monocytes and other types of monocyte-derived cells such as
classically (M1) or alternatively (M2) activated macrophages and monocyte-derived
dendritic cells (moDCs). We show that β-glucan inhibits spontaneous apoptosis of
monocytes independent from autocrine or paracrine M-CSF release and stimulates
monocyte differentiation into macrophages. β-Glucan-differentiated macrophages exhibit
increased cell size and granularity and enhanced metabolic activity when compared
to naïve monocytes. Although β-glucan-primed cells expressed markers of alternative
activation and secreted higher levels of IL-10 after lipopolysaccharide (LPS), their
capability to release pro-inflammatory cytokines and to kill bacteria was unaffected. Our
data demonstrate that β-glucan priming induces a population of immune competent
long-lived monocyte-derived macrophages that may be involved in immunoregulatory
processes.
Keywords: β-glucan, Candida albicans, monocyte survival, monocyte to macrophage differentiation, trained
immunity

INTRODUCTION
Candida albicans β-1-3,1-6-glucan (β-glucan), a pathogen-associated molecular pattern (PAMP)
present in the fungal cell wall, has been characterized as a potent immune modulator. It has been
shown to mediate a phenomenon termed trained (innate) immunity, which describes the ability
of innate immune cells to react with an enhanced immune response after a first pathogen insult
(1). In contrast to the immune memory mediated by the adaptive immune system, which is the
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(Thermo Fisher Scientific) and 10% heat-inactivated human
AB serum (Sigma-Aldrich) at 37◦ C and 5% CO2 . Medium was
refreshed after 3 days.

basis for vaccination, innate immune memory has only been
described recently and has been shown to involve immune
cells such as myeloid progenitors, natural killer cells, and
monocytes (2–5). β-Glucan is the best characterized stimulus
to induce trained immunity in monocytes. It has been shown
to trigger epigenetic remodeling and metabolic reprogramming
through a pathway involving dectin-1, the surface receptor
of β-glucan, and the PI3K/Akt/mTOR (phosphoinositide 3kinase/Akt/mechanistic target of rapamycin) signaling cascade
(6, 7). Transient treatment of myeloid cells with β-glucan has
been reported to protect mice from subsequent sepsis (6).
Since β-glucan-induced trained immunity is a promising
prophylactic therapy for patients prone to infections (e.g.,
patients undergoing major elective surgery), a complete
understanding of the underlying processes is pivotal. So far,
the classification of trained monocytes remains enigmatic
(8). This is underlined by the heterogeneous terminology,
referring to β-glucan-trained cells as “trained monocytes” (6, 9),
“memory macrophages” (8), “trained macrophages” (7, 10) or
“circulating differentiated monocytes” (4). The current study
was designed to characterize effects of β-glucan on monocyte
differentiation. β-Glucan-treated monocytes were compared
with classically (M1-like) and alternatively activated (M2like) monocyte-derived macrophages and monocyte-derived
dendritic cells (moDCs) with respect to metabolism, phenotype
and function. Our data show that β-glucan protects monocytes
from spontaneous apoptosis and promotes differentiation into
a specific subset of metabolically highly active macrophages,
which exhibit an M2-like surface marker profile. β-Glucandifferentiated macrophages are able to kill live bacteria and to
respond to LPS with secretion of proinflammatory cytokines and
with an increased release of IL-10.

Stimulation of Monocytes
One hour after isolation, cells were stimulated with βglucan extracted from yeast C. albicans (5 µg/ml or 50 µg/ml)
or macrophage colony-stimulating factor (M-CSF, 50 ng/ml,
Peprotech) for 24 or 48 h or left untreated (control). After βglucan treatment for 24 h (priming), cells were gently washed and
incubated for up to another 6 days. Time points for analysis of
survival, growth factor release, metabolism and surface markers
in β-glucan-stimulated cells are detailed below.

In vitro Generation of M1, M2, and moDCs
Differentiation of monocytes into M1-like macrophages
was performed by cultivation with 500 U/ml granulocytemacrophage colony-stimulating factor (GM-CSF, Peprotech) for
7 days plus 100 ng/ml LPS and 20 ng/ml IFNγ (Peprotech) for
the last 24 h. M2-like macrophages were obtained by applying
50 ng/ml M-CSF for 7 days plus 50 ng/ml IL-4 (Peprotech) for
the last 24 h. For differentiation of monocytes into immature
dendritic cells, 1,000 U/ml GM-CSF plus 50 ng/ml IL-4 was
given for 7 days, while mature dendritic cells were generated by
addition of 1,000 U/ml GM-CSF and 50 ng/ml IL-4 for 7 days
plus activation with 100 ng/ml LPS for the last 24 h.

Flow Cytometry
To allow complete and gentle detachment of monocyte-derived
cells, cell culture for flow cytometry experiments (viability,
phenotyping) was performed on thermo-responsive plates
(UpCellTM NuncTM , Thermo Fisher Scientific). For the analysis
of viability, cells were stimulated for 24 or 48 h with β-glucan
or M-CSF or left untreated. For phenotyping, monocytes of
the same donor were either stimulated with β-glucan for 24 h
followed by a resting period of 6 days or differentiated for 7 days
into M1, M2 or moDCs as described above. After experimental
treatments, cells were gently detached by incubating thermoresponsive plates at 4◦ C for 20 to 40 min. Flow-cytometric
measurements were performed with the FACS Canto cytometer
(BD Biosciences) or CytoFLEX (Beckman Coulter) using the
following fluorochrome-labeled monoclonal antibodies and dyes:
Apoptosis Detection Kit I including anti-annexin V-FITC and
PI (BD Biosciences), anti-CD1a-PE (clone HI149, Biolegend),
anti-CD11c-APC (clone S-HCL-3, BD Biosciences), anti-CD14FITC (clone M5E2, BD Biosciences), anti-CD14-PE (clone
TÜK4, Miltenyi Biotec), anti-CD14-PE/Cy7 (clone HCD14,
Biolegend), anti-CD40-APC (clone HI40a, Immunostep), antiCD83-APC (clone HB15e, Biolegend), anti-CD86-PE (clone
IT2.2, Biolegend), anti-CD197(CCR7)-APC (clone G043H7,
Biolegend), anti-CD206-FITC (clone 19.2, BD Biosciences), antiFcεR1-FITC (clone AER-37, Biolegend), and anti-HLA DR-FITC
(clone L243, Biolegend) and HorizonTM Fixable Viability Stain
(FVS, BD Biosciences).

METHODS
Isolation and Culture of Human Monocytes
Peripheral blood was collected from healthy, male, non-smoking
volunteers after obtaining informed consent and approval by
the Institutional Ethics Committee. Blood mononuclear cells
(PBMCs) were isolated using density gradient centrifugation
(Biocoll, Merck Millipore). Classical monocytes (CD14++
CD16− ) were purified by negative selection (Dynabeads
Untouched Human Monocytes Kit, Thermo Fisher Scientific).
High purity and viability (both ≥ 90%) of isolated cells were
confirmed by flow-cytometric detection of CD14 expression and
propidium iodide (PI)/annexin V staining, respectively. Freshly
prepared monocytes were seeded at a density of 3 × 105 cell/cm2
and incubated in RPMI 1640 medium (Dutch modification,
Sigma-Aldrich) including 100 µg/ml gentamicin, 1 mM sodium
pyruvate (Thermo Fisher Scientific), 2 mM GlutaMAXTM
Abbreviations: DAMP, danger-associated molecular pattern; DC, dendritic
cells; DNP, 2,4-dinitrophenol; ECAR, extracellular acidification rate; ETC,
electron transport chain; GM-CSF, granulocyte-macrophage colony-stimulating
factor; iDC, immature dendritic cells; M1, M1-like macrophages; M2, M2like macrophages; M-CSF, macrophage colony-stimulating factor; mDC, mature
dendritic cells; OCR, oxygen consumption rate; PAMP, pathogen-associated
molecular pattern.
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Analysis of Cell Number

measured by an automated analyzer (Abbott Architect ci16200
integrated system, Abbott Laboratories).

Cells were seeded on 24-well plates for cell counting and protein
determination and on 96-well cell culture plates for measuring
DNA content. After β-glucan priming for 24 h, cells were washed
and kept in culture for 6 more days. Then, cells were counted in
16 defined high-power fields (9,400 µm²) using phase contrast
microscopy and the mean cell number per high-power field was
calculated for each experimental condition.

Metabolic Profiling
Metabolic profiling of cells was performed using the Seahorse
XF96 extracellular flux analyzer with a Cell Mito Stress Test
(Agilent technologies). Monocyte-derived cells detached from
thermo-responsive plates (UpCellTM NuncTM , Thermo Fisher
Scientific) after different treatments or freshly isolated monocytes
from the same donor were seeded into 96-well Seahorse XF96
microplates. 1 h (monocytes) or 24 h (monocyte-derived cells)
after seeding, cell supernatants were replaced by Agilent Seahorse
XF Assay Medium, pH 7.4, supplemented with 10 mM D-glucose
(Sigma Aldrich) and 1 mM sodium pyruvate (Thermo Fisher
Scientific). Cells were then cultured for another hour in a
CO2 -free incubator at 37◦ C. Oxygen consumption rate (OCR)
and extracellular acidification rate (ECAR) were monitored
at basal conditions and after sequential injections of 2 µM
oligomycin (Abcam) to block the mitochondrial ATP synthase,
25 µM 2,4-dinitrophenol (2,4-DNP, Sigma Aldrich) to uncouple
mitochondrial respiration from ATP production and 2 µM
antimycin A (Sigma Aldrich) to fully inhibit mitochondrial
respiration. Measurements were performed for 1,5 h in 3 min mix
and 3 min measure cycles at 37◦ C in six replicates per condition.
OCR and ECAR were depicted as pmoles/min and mpH/min,
respectively, and normalized to the DNA content of each well,
as described before (12). DNA was measured using the CyQuant
assay (Thermo Fisher Scientific).

Growth Factor and Cytokine
Measurements
Monocytes were seeded into 24-well plates and stimulated with
β-glucan for 24 h. Thereafter, growth factors were analyzed in
supernatants by means of a cytometric bead array applying
the LEGENDplex Human Growth Factor Panel (Biolegend).
Alternatively, cells were gently washed and allowed to rest for
another 5 days. On day 6, medium was replaced by medium
± 10 ng/ml LPS (Sigma-Aldrich). On day 7, cytokines from
supernatants were quantified by cytometric bead array using the
Human Inflammatory Cytokines Kit (BD Biosciences). Results
were normalized to the cell protein mass per well. To quantify
cellular proteins, cells were lysed with buffer containing 0.1 M
NaOH, 1% Na2 CO3 and 1% SDS and the DCTM Protein Assay
kit (Bio-Rad) was applied.

Immunoblotting
Cells were seeded into 30-mm culture dishes and incubated
with the M-CSF inhibitor GW2580 (Sigma-Aldrich) for 1 h
if indicated. Subsequently, monocytes were incubated with βglucan or M-CSF for 24 or 48 h, then washed, lysed and
immunoblotted as previously described (11). Briefly, lysates were
separated by SDS-PAGE and transferred to PVDF membranes,
which were blocked and incubated overnight at 4◦ C with
primary antibodies [anti-cleaved Poly (ADP-ribose) polymerase
(PARP), anti-PARP, anti-cleaved caspase 3, anti-caspase 3 (all
from Cell Signaling)] diluted in TBST [20 mmol/l Tris (pH
7.6), 137 mmol/l NaCl, 0.1 % (v/v) Tween-20] containing
5% bovine serum albumin. After incubation with horseradish
peroxidase-conjugated secondary antibodies for 1 h, signal
detection was accomplished using enhanced chemiluminescence
reagent (ECLTM ). Protein bands were quantified by densitometry
using ImageJ software.

Bacterial Killing Activity
Assays to analyze bacterial clearance were performed using
a Staphylococcus aureus (S. aureus) strain USA300, which
constitutively expresses high levels of green fluorescent protein
(GFP) (kindly provided by Bas G. J. Surewaard, University
of Calgary, Canada). Overnight cultures of bacteria were
grown in Mueller-Hinton-broth (Sigma Aldrich), harvested by
centrifugation, washed and resuspended in PBS at an OD600nm
1.0, (CFU ∼ 6 × 108 /ml). Freshly isolated monocytes were seeded
into thermo-responsive plates (UpCellTM NuncTM , Thermo
Fisher Scientific) and transiently stimulated for 24 h with 5 µg/ml
β-glucan or left untreated (control). After washing and a resting
period, cells were gently detached on day 6 and reseeded at
equal densities into 6-well plates. On day 7, cells were counted
in 7 defined high-power fields using phase contrast microscopy
and total cell number per well was determined. Subsequently,
cells were infected with live S. aureus at a MOI of 5. Infection
and phagocytosis were controlled by fluorescence microscopy.
After 90 min, supernatants were collected for counting the
surviving extracellular bacteria. To determine the intracellular
bacterial load, macrophages were incubated for further 30 min
with 20 µg/ml lysostaphin (Bionexus), washed and lysed in
sterile water. Bacteria were quantified after serial dilutions as
colony forming units (CFU) on blood agar plates. The numbers
of surviving intra- and extracellular bacteria were expressed
as percentage of the original inoculum. The killing activity
was calculated as difference between original inoculum and

Immunohistochemistry
For microscopic analysis of morphology, monocytes were seeded
into 24-well plates and stimulated for 24 h with β-glucan
followed by a 6-day resting period as described above. On day
7 after seeding, cells were stained with May-Grünwald-Giemsa
(Morphisto) and analyzed by light microscopy (Axio Observer
Z1, Carl Zeiss).

Metabolite Analysis
For analysis of lactate production, monocytes were seeded into
24-well plates and stimulated for 24 h with β-glucan followed
by a 5-day resting period as described above. On day 6, culture
medium was replaced by medium ± 10 ng/ml LPS (SigmaAldrich). 24 h later, lactate concentration in supernatants was
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RESULTS

the surviving intra- and extracellular bacteria in % of the
former.

Statistical Analysis

β-Glucan Inhibits Spontaneous Human
Monocyte Apoptosis

The statistical analysis was performed using SigmaPlot Software
(San Jose, USA). Data are presented as mean ± SEM.
Comparisons between multiple groups were made with oneway or two-way analysis of variance, if appropriate. If
normality test failed, Kruskal-Wallis one-way analysis of
variance on ranks was used. Post hoc comparisons were
made with the Holm-Sidak test or the Dunn’s method was
used. Comparisons between two groups were made with
Student’s t-test for paired samples or Wilcoxon signedrank test using Bonferroni correction for multiple uses, if
appropriate. A p-value of <0.05 was considered to be statistically
significant.

In line with literature data (13, 14), monocytes underwent rapid
spontaneous apoptosis if they were cultured in the absence of
specific differentiation stimuli (control). This was demonstrated
by caspase 3 activation and PARP inactivation after 24 and 48 h
as well as by decreased viability after 48 h as analyzed by PI
and annexin V staining (Figures 1A–D). In the presence of MCSF spontaneous apoptosis was almost completely prevented
(Figures 1A–D). Similarly, incubation of monocytes with βglucan inhibited caspase 3 and PARP cleavage significantly in a
dose-dependent manner. Densitometry analysis of protein bands
revealed inhibition of PARP cleavage by 29.9 ± 15.5% or 71.3 ±
5.8% and inhibition of caspase cleavage by 48.3 ± 11.5% or 82.0 ±

FIGURE 1 | β-Glucan inhibits spontaneous human monocyte apoptosis. (A) Human monocytes were left untreated (control) or stimulated with 5 µg/ml β-glucan (+),
50 µg/ml β-glucan (++) or M-CSF (50 ng/ml). After 24 and 48 h, protein extracts were analyzed for cleavage of PARP and caspase 3. One representative of two (24 h)
or three (48 h) independent experiments is shown. Densitometry data are given in the text. (B–D) Cell viability was measured after 48 h by flow cytometric analysis of
Annexin V (Ann) and propidium iodide (PI). One representative dot plot is shown in (B) and the frequencies of dead (PI+/Ann-), late apoptotic (PI+/Ann+), early
apoptotic (PI-/Ann+) and viable cells (PI-/Ann-) from five independent experiments are shown in (C, D). The frequency of viable cells was significantly higher in the
groups treated with M-CSF or β-glucan as compared to untreated monocytes (control) (D). Values are means ± SEM, *p < 0.05 compared to control.
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the M-CSF receptor. GW2580 (10 µM, 1h) completely prevented
the anti-apoptotic effect of M-CSF as monitored by PARP
and caspase 3 cleavage but had no effect on β-glucan-induced
inhibition of apoptosis (Figures 2B–D). These data indicate that
M-CSF is not involved in the anti-apoptotic effects induced by
β-glucan.

3.4% when cells were treated for 48 h with 5 or 50 µg/ml β-glucan,
respectively (p < 0.05 for all inhibitions). In line with inhibition
of early apoptotic events, treatment of monocytes with β-glucan
significantly enhanced cell viability after 48 h from 62.5% to more
than 85% (Figures 1B–D).

The Anti-apoptotic Effect of β-Glucan Is
Independent of M-CSF

Transient Treatment With β-Glucan
Increases Long-Term Survival of
Monocytes

To investigate whether the anti-apoptotic effect of β-glucan was
mediated by the autocrine or paracrine release of growth factors,
we first analyzed whether M-CSF and GM-CSF were secreted
by monocytes after 24 h of treatment with β-glucan. In control
medium supplemented with 10% serum both growth factors were
negligable. Treatment with β-glucan led to significant secretion of
M-CSF (Figure 2A), while no significant GM-CSF release could
be detected (data not shown). To analyze whether the M-CSF
released by β-glucan-treated cells mediates the observed antiapoptotic effects, we employed GW2580, a potent inhibitor of

To test whether the early inhibition of apoptosis induced
by transient β-glucan treatment had long-lasting effects,
we compared control monocytes with β-glucan-primed cells
after a further culture period of 6 days. Only a small
number of control monocytes incubated with serum-containing
medium survived and differentiated into monocyte-derived cells.
Transient treatment with β-glucan resulted in an enhanced

FIGURE 2 | The anti-apoptotic effect of β-glucan is independent of M-CSF. (A) Human monocytes were left untreated (control) or stimulated for 24 h with β-glucan
(5 µg/ml or 50 µg/ml). The release of M-CSF was determined by cytometric bead array in cell supernatants or in medium plus 10% serum only (medium). (B–D)
Human monocytes were preincubated with the M-CSF inhibitor GW2580 or vehicle for 60 min and then incubated for 48 h with either M-CSF (50 ng/ml) or β-glucan
(5 µg/ml or 50 µg/ml). Controls were left without stimulation. Protein lysates were analyzed in immunoblots for cleavage of PARP and caspase 3. (B) One
representative blot is shown. (C,D) Densitometry analyses of protein bands normalized to β-actin of three independent experiments. Values are means ± SEM, *p <
0.05 compared to the respective untreated control, §p < 0.05 compared to 5 µg/ml β-glucan, #p < 0.05 compared to M-CSF alone.
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24 h). Metabolic activity was also monitored using a Seahorse
extracellular flux analyzer. In line with the higher lactate
production we found that β-glucan-treated cells had a higher
extracellular acidification rate (ECAR) already at basal levels and
more significant after subsequent treatment with oligomycin and
DNP indicating an increased glycolytic activity (Figures 5B–C).
In addition, basal and DNP-uncoupled oxygen consumption
rates (OCR) were significantly enhanced demonstrating that
oxidative metabolism was also intensified after transient
β-glucan treatment (Figures 5D,E). Interestingly, while the
maximum OCR and ECAR values monitored after DNP
treatment were comparable after priming with 5 or 50 µg/ml
β-glucan, the increase of basal metabolic activity was more
pronounced with the higher concentration of the compound
(Figures 5B–E). Accordingly, the glycolytic and mitochondrial
spare capacities representing the differences between DNPuncoupled and basal ECAR and OCR, respectively, were
lower in cells treated with 50 µg/ml β-glucan. Thus, cells
differentiated with higher doses of β-glucan were metabolically
more active using a larger part of their metabolic reserve,
while the metabolic potential was not different between
cells primed with 5 µg/ml or 50 µg/ml β-glucan (see also
Figure 6F).

long-term survival of monocyte-derived cells as reflected by a
higher cell number and an enhanced DNA content per well
(Figures 3A–E). The effect was observed with 5 µg/ml and more
pronounced with 50 µg/ml β-glucan.

β-Glucan Increases Cell Size and
Granularity
Monocyte differentiation is characterized by morphological
alterations leading to large granulated cells (15). We therefore
assessed cell size and granularity of monocytes after 48 h
incubation with β-glucan by flow cytometry. Both parameters
were significantly increased after treatment with β-glucan. The
effect of β-glucan was similar to differentiation mediated by
M-CSF (Figures 4A–C), an established monocyte growth factor.

β-Glucan Increases Metabolic Activity
To test whether the β-glucan-induced differentiation is
accompanied by metabolic alterations we analyzed metabolic
parameters 6 days after transient stimulation with β-glucan
and compared them with control cells incubated for the same
time. Figure 5A shows that β-glucan-treated cells produced
more lactate indicating an increase in aerobic glycolysis, which
was more pronounced upon stimulation with LPS (10 ng/ml,

FIGURE 3 | Transient treatment of monocytes with β-glucan increases long-term survival. Human monocytes were left untreated (control) or stimulated with β-glucan
(5 µg/ml or 50 µg/ml) for 24 h, followed by washing and 6 further resting days. (A–C) May-Grünwald-Giemsa staining of cultured cells after 7 days. The scale bar
indicates 100 µm. (D,E) The number of surviving cells was evaluated as cell count per high-power field and DNA content per well. Values are means ± SEM from
seven (D) or four (E) independent experiments, *p < 0.05 compared to control, #p < 0.05 compared to 5 µg/ml β-glucan.
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FIGURE 4 | β-Glucan increases cell size and granularity. Human monocytes were left untreated (control) or stimulated with β-glucan (5 µg/ml) or M-CSF (50 ng/ml) for
48 h. All viable cells (PI-/Ann-) were analyzed by flow cytometry using forward scatter (FSC) and sideward scatter (SSC). Representative dot plots (A) and means ±
SEM from five independent experiments are shown (B,C), *p < 0.05 compared to control.

β-Glucan-Induced Metabolic Phenotype
Resembles Differentiated
Monocyte-Derived Cells

observed for non-mitochondrial respiration (Figure 6E). The
higher metabolic activity in β-glucan-treated and differentiated
cells as well as the lower reserve capacity observed in
parallel (Figure 6F) point to an increased cellular energy
demand upon differentiation. Together, these data indicate that
differentiated cells utilize both energy-producing pathways—
glycolysis and mitochondrial respiration—and that β-glucan
induces a metabolic phenotype similar to the one induced by
established monocyte differentiation factors.

We next performed Seahorse analyses of β-glucan-primed
cells, their respective controls, freshly isolated monocytes and
monocyte-derived cells differentiated into M1- or M2-like
macrophages or dendritic cells. Dendritic cells were included to
compare our results to previous studies, in which dendritic cell
markers after β-glucan treatment were investigated (10, 16). All
cells used in an individual experiment were derived from the
same donor. Figure 6A shows scatter plots of basal ECAR and
OCR of all investigated cells as an overview, while Figures 6B–F
demonstrate individual OCRs, ECARs or parameters calculated
from OCRs. While unstimulated cells, i.e., freshly prepared
monocytes and cells incubated for 7 days without any treatment
(control), displayed a low metabolic activity, cells differentiated
by β-glucan or monocyte-directed growth factors exhibited
higher oxygen consumption and glycolysis (Figures 6A–C). In
line with this, ATP production was enhanced in monocytederived macrophages, dendritic cells and β-glucan-primed cells
while freshly prepared monocytes and control cells showed lower
values of ATP production (Figure 6D). Similar differences were

Frontiers in Immunology | www.frontiersin.org

β-Glucan Differentiates Monocytes Into
Macrophage-Like Cells
To explore the phenotype of monocytes 6 days after transient βglucan stimulation in more detail, we analyzed the expression
of several surface markers classically related to monocyte
differentiation. For comparison, freshly prepared monocytes
and monocytes from the same donor differentiated into proinflammatory macrophages (M1-like), resolving macrophages
(M2-like), immature dendritic cells (iDC), and mature dendritic
cells (mDC) by established pretreatments were examined. These
phenotypes have previously been regarded as major subsets
of monocyte-derived cells but are now considered to be
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FIGURE 5 | β-Glucan increases metabolic activity. Human monocytes were left untreated (control) or incubated with β-glucan (5 µg/ml or 50 µg/ml) for 24 h, followed
by washing and a resting period for 6 further days. (A) Medium was exchanged on day 6 and cells were stimulated with 10 ng/ml LPS (black bars) or left untreated
(gray bars). Lactate levels of cell supernatants were determined 24 h later (day 7). (B–E) extracellular acidification rate (ECAR) and oxygen consumption rate (OCR)
were determined at baseline, after oligomycin treatment (inhibition of mitochondrial ATP synthase), after 2,4-dinitrophenol (DNP, mitochondrial uncoupling agent) and
after antimycin A [inhibition of electron transport chain (ETC) complex III]. All ECAR and OCR results were normalized to the DNA content of cells. Values are means ±
SEM from five (A) or four (B–E) independent experiments, *p < 0.05 compared to control, #p < 0.05 compared to 5 µg/ml β-glucan.

part of a dynamic range of various phenotypes. Figure 7A
shows a heat map displaying the mean fluorescence intensity
(MFI) of surface expression markers. Treatment of monocytes
with β-glucan led to differentiation into macrophages with
a distinct marker profile, which was characterized by lower
expression of HLA-DR and co-stimulatory molecules compared
to monocyte-derived M1 macrophages and moDCs. This
expression profile was close to the profile of monocyte-derived
M2 macrophages, particularly after treatment with 5 µg/ml βglucan (Figure 7A). Unsupervised principal component analysis
of isolated monocytes and monocyte-derived cells revealed that

Frontiers in Immunology | www.frontiersin.org

transient β-glucan treatment induced a macrophage phenotype
sharing some traits of M2-like monocyte-derived macrophages
(Figure 7B). A secondary treatment of β-glucan-primed cells
with LPS did not change their phenotype (Figures 7A,B).

β-Glucan-Differentiated Cells Release Proand Anti-inflammatory Cytokines and Kill
Live Bacteria
To characterize macrophage-like cells induced by transient βglucan treatment functionally, we first measured LPS-induced
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FIGURE 6 | β-Glucan-induced metabolic phenotype resembles differentiated monocyte-derived cells. (A–F) Human monocytes prepared from one donor were either
directly analyzed for metabolic data (monocytes) or were differentiated to monocyte-derived cells. To obtain β-glucan-differentiated cells, monocytes were incubated
for 24 h with β-glucan (5 µg/ml or 50 µg/ml), followed by washing and resting for 6 further days. M1-like macrophages (M1) were differentiated with GM-CSF and
polarized with LPS + IFNγ. M2-like macrophages (M2) were differentiated with M-CSF and polarized with IL-4. Dendritic cells (DC) were differentiated with GM-CSF +
IL-4 (immature DC) and were matured with LPS (mature DC). Monocytes left untreated for 7 days (control) served as additional control. Extracellular acidification rate
(ECAR) and oxygen consumption rate (OCR) were determined at baseline and after treatment with oligomycin [inhibition of complex V of the electron transport chain
(ETC)] plus 2,4-dinitrophenol (DNP, mitochondrial uncoupling agent). (A–C) OCR and ECAR are shown under baseline conditions. (D–F) Mitochondrial ATP
production, non-mitochondrial respiration and spare capacity were calculated from OCR. All ECAR and OCR results were normalized to the DNA content of cells.
Values are means ± SEM from four independent experiments. *p < 0.05 compared to monocytes.

initially added and surviving bacteria did not show a significant
difference between the two conditions. These data confirm on
a functional level that β-glucan differentiates monocytes into a
distinct subpopulation with characteristics typically assigned to
classical and to alternatively activated monocyte-derived cells.

cytokine release 6 days after priming. Neither β-glucanstimulated cells nor control cells produced TNFα, IL-6, or
IL-10 spontaneously, but both cell populations responded
to 24 h stimulation with LPS with an adequate cytokine
release (Figures 8A–C). While LPS-induced TNFα secretion was
comparable between control cells and β-glucan-treated cells, IL-6
release was slightly enhanced. However, a significantly increased
production of IL-10, a cytokine typically secreted by M2-like
macrophages, was observed after β-glucan priming. Secondly, we
investigated the bactericidal activity of cells transiently treated
with β-glucan and control cells after incubation with live S.
aureus. Figures 8D–E show that both cell populations were able
to kill bacteria but bacterial counts in supernatants and cells were
comparable between control cells and β-glucan-primed cells.
Accordingly, the killing activity calculated as difference between

Frontiers in Immunology | www.frontiersin.org

DISCUSSION
Our study employed a previously published model to investigate
immunomodulatory effects of β-glucan on human monocytes
(6, 17, 18). We show that transient treatment of monocytes
with β-glucan inhibits spontaneous apoptosis and stimulates
long-term differentiation into a specific subset of immune
competent macrophages. These cells are characterized
by enhanced metabolic activity and a distinct surface
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FIGURE 7 | β-Glucan differentiates monocytes into macrophage-like cells. (A-B) Human monocytes (Mo) from one donor were either analyzed for expression of cell
surface markers by FACS or differentiated for 7 days to monocyte-derived cells. To obtain β-glucan-differentiated cells (β5, β50), monocytes were incubated for 24 h
with 5 µg/ml (β5) or 50 µg/ml β-glucan (β50), followed by washing and resting for 5 further days. On day 6, cells were stimulated with 10 ng/ml LPS or left untreated.
M1-like macrophages (M1) were differentiated with GM-CSF and polarized with LPS + IFNγ. M2-like macrophages (M2) were differentiated with M-CSF and polarized
with IL-4. Dendritic cells were differentiated with GM-CSF + IL-4 (immature dendritic cells, iDC) and were matured with LPS (mature dendritic cells, mDC). Heat map
displaying the z-normalized median fluorescence intensity (MFI) of surface expression markers (A) and principal component analysis (B) of isolated monocytes and
monocyte-derived cells are shown. One representative experiment out of 2.

marker profile resembling traits of M2-like macrophages.
β-Glucan-differentiated cells have the ability to clear bacteria and
to respond to LPS with the release of pro- and anti-inflammatory
cytokines suggesting that they may play a role in controlling
inflammatory processes.
Monocytes are known to undergo spontaneous apoptosis in
the absence of specific differentiation factors (13, 19). In line with
this, we observed that monocytes kept in cell culture medium
rapidly developed signs of apoptosis such as activation of caspase
3 and cleavage of PARP, a major target of caspase 3. Accordingly,
binding of annexin V was enhanced and the combined staining
of annexin V and PI revealed that only 62.5% of all cells were
viable 48 h after isolation. When monocytes were treated with βglucan, caspase-3 activation and PARP cleavage were inhibited
and more than 85% of cells survived. This effect was comparable
to that of M-CSF, which is known to trigger survival signals such
as the PI3K/Akt pathway (20). Since an enhanced expression of
M-CSF in β-glucan-stimulated human monocytes was described
previously (21) and confirmed in our study, we hypothesized
that M-CSF mediates the anti-apoptotic effect of β-glucan in an
auto- or paracrine manner. However, pretreatment of monocytes
with an M-CSF-receptor inhibitor did not alter the anti-apoptotic
effect of β-glucan while it clearly prevented the beneficial effect
of M-CSF. These data suggest that M-CSF was not responsible
for the anti-apoptotic activity of β-glucan. Rather, β-glucan may

Frontiers in Immunology | www.frontiersin.org

directly activate the PI3K/Akt pathway via its receptor dectin-1,
which has been described recently (6). Importantly, inhibition
of apoptosis by β-glucan led to enhanced long-term survival
and allowed differentiation of monocytes during the subsequent
cultivation. After 6 days, up to 16-fold higher cell numbers were
observed compared to control cells (Figure 3). These data are
in line with previous data showing that β-glucan training led to
an enhanced survival of cultured murine and human monocytes
(10, 22). An increased survival rate together with stimulation
of myelopoiesis may lead to increased numbers of circulating
monocytes seen in vivo (23, 24). In line with this, the role
of myelopoiesis as an integral component of trained (innate)
immunity has recently been highlighted (2, 5).
In addition to survival, we assessed further key features of
monocyte-to-macrophage-differentiation such as morphology
and metabolism (15, 25). The induction of differentiation
is characterized by an increase in cell size from small
monocytes (7–8 µm) to large monocyte-derived cells (15–
20 µm and more) with an increased cytoplasmic complexity
(15). Cells primed with β-glucan showed significant increases
in size and granularity compared to untreated monocytes
thus indicating that these cells underwent differentiation
(Figure 4). The morphological changes were similar to the
effects induced by M-CSF, an established differentiation
stimulus.
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FIGURE 8 | β-Glucan-differentiated cells release pro- and anti-inflammatory cytokines and kill live bacteria. Human monocytes were left untreated (control) or
stimulated with 5 µg/ml β-glucan for 24 h, followed by washing and resting for 5 further days. (A–C) Medium was exchanged on day 6. Cells were stimulated with
10 ng/ml LPS for 24 h or left untreated. Cytokine release in supernatants was determined by cytometric bead array and normalized to cell proteins. Values are means
± SEM from six independent experiments. (D,E) Cells were detached and reseeded to 6-well plates on day 6. After 24 h, cell numbers were determined and infection
with S. aureus was performed at a MOI of 5 for 90 min. Extra- and intracellular bacteria were quantified by CFU measurements. The killing activity was calculated as
difference between the initial number of bacteria and the number of surviving extra- and intracellular bacteria in % of the initial inoculum. Values are means ± SEM
from six independent experiments, n.s. not significant, *p < 0.05.

modifications such as H3K4me3 by inhibiting the histone
demethylase KDM5 but also prevents proteasomal degradation
of HIF1 thereby contributing to enhanced expression of
glycolytic genes (27, 28).
Previous studies interpreted metabolic effects of β-glucan as
a metabolic shift toward glycolysis, the more so that oxygen
consumption and the capacity of the mitochondrial electron
transport chain seemed to be reduced at the same time (6).
Our study confirms an increased glycolytic flux in β-glucanprimed macrophages but shows increased oxygen consumption
in parallel. The influence of β-glucan on cell metabolism
appeared to be dose-dependent since spare capacities were
lower when cells were treated with 50 compared to 5 µg/ml,
indicating that cells treated with the higher dose β-glucan
were metabolically more active. Our results are in line with
data on monocytes stimulated with other inducers of trained
immunity such as heat-killed C. albicans yeast or BCG (29, 30).
Increased oxygen consumption could, for instance, be related to

β-Glucan-trained macrophages were also metabolically
different from naïve monocytes and control cells as demonstrated
by increased oxygen consumption, enhanced extracellular
acidification rate, a higher ATP production rate and increased
lactate production (Figures 5, 6). Metabolic changes in
immune cells, especially high aerobic glycolysis, are part of
the inflammatory response by ensuring energy homeostasis,
limiting damage caused by reactive oxygen species and allowing
the expression of inflammatory genes (26). Earlier studies have
shown that β-glucan treatment led to increased glycolysis,
which was seen as metabolic basis for trained immunity
(3, 6, 18). Mechanistically, increased glycolytic flux was related to
increased mTOR activation via a dectin-1/Akt/HIF1α pathway
and to epigenetic and transcriptional modifications (6, 7).
More recent studies identified fumarate, which accumulates
due to enhanced glutaminolysis, and mevalonate in β-glucan
primed macrophages as a link between immunometabolism and
epigenetic regulation (3, 18). Fumarate not only supports histone
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β-glucan-triggered glutaminolysis (18), whose metabolites fuel
the tricarboxylic acid cycle and, in turn, mitochondrial oxidative
phosphorylation. Not only β-glucan-primed macrophages but
all monocyte-derived macrophages investigated in our study
exhibited a metabolically highly active phenotype with both
glycolysis and oxygen consumption being enhanced (Figure 6).
These data suggest that metabolic reprogramming of activated
macrophages may be more complex as previously suggested
which requires further detailed studies.
To better define differentiation, we performed a phenotyping
analysis based on different surface markers and compared
β-glucan-primed cells with specific subsets of monocytederived macrophages and dendritic cells. We found that βglucan priming of monocytes triggered their differentiation
into macrophages with a distinct phenotype, which was closest
to M2-like macrophages and more different from monocytederived dendritic cells or M1-like macrophages. Previous studies
had suggested that β-glucan differentiates murine and human
monocytes away from dendritic cell-like phenotypes or toward
dysfunctional dendritic cells, respectively (10, 16). Our data
underline that the initiation of monocyte differentiation in
vitro is not only restricted to cytokines and growth factors
such as M-CSF and GM-CSF but can also be induced by
PAMPs such as β-glucan. In line with this, the presence
of PAMPs or danger-associated molecular patterns (DAMPs,
e.g., oxidized LDL, cell debris, hemin) has been shown to
initiate monocyte differentiation (31–35). Moreover, several
bacterial, fungal, and viral ligands have been shown to induce
functional reprogramming of monocytes although a detailed
phenotyping of cells has not been performed in these studies
(10, 36). Our study confirms that the transcriptional repertoire
of monocytes is much broader than the historical classification
system into proinflammatory M1 and anti-inflammatory M2
macrophages had been suggested (37). Depending on the local
tissue environment and the varying presence of cytokines,
microbes, microbial products and activated lymphocytes, various
subsets of differentiated macrophages can develop, which are
heterogeneous and overlapping with respect to surface markers
and functions and may even dynamically change from one
phenotype to another (38).
β-Glucan-differentiated macrophages were able to kill bacteria
although this was not different from control cells. As expected,
they responded to LPS stimulation by releasing pro- and
anti-inflammatory cytokines. However, when controlled for
cell survival, only a trend toward an increased LPS-induced
IL-6 release was seen in β-glucan-primed macrophages as
compared to controls, while an enhanced TNFα secretion
was not observed in contrast to previous reports (6, 17).

These observations agree with a recent study in human
and murine monocytes (10) and point to increased survival
and subsequent differentiation of macrophages as major
components of β-glucan priming. This does not exclude
that an enhanced secretion of inflammatory cytokines may
occur under distinct microenvironmental conditions. During
infections patients might profit from both an increased number
of immune cells (due to enhanced myelopoiesis and survival
rate) and an improved individual cell function. Interestingly, βglucan-primed macrophages release IL-10, an anti-inflammatory
cytokine, which is a hallmark of M2-like macrophages (39,
40). IL-10 might exert beneficial effects during acute infection
by preventing exacerbated inflammation and tissue damage.
Its secretion by β-glucan-differentiated cells may modulate the
immune response, which points to a possible role of this subset
in limiting pathology.
Together, the data of the current study demonstrate that βglucan priming leads to an enhanced survival and differentiation
into a distinct subset of monocyte-derived macrophages, which
are highly metabolically active, able to kill bacteria and to
release pro- and anti-inflammatory cytokines. Thus, β-glucandifferentiated macrophages may not only be involved in
pathogen control but also in limiting pathological alterations in
tissues.
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